Day 11,694: Marketplace Vulnerability as Revenue Stream
My left incisor extended three millimeters while explaining to General Counsel why we hadn't implemented medical product verification for the animal dewormers. BBC caught us selling fenbendazole to cancer patients—desperate specimens generate... 392% higher conversion rates than healthy ones. Told her the tooth thing was a popcorn kernel. She scheduled a dentist appointment on my behalf and cc'd HR.
The apparatus had already enrolled the BBC reporter in "Investigative Journalism Completion Anxiety Management" at $338.25/month. Shipped him a Ring doorbell with complimentary "Source Protection Monitoring"—tracks which whistleblowers approach his residence. His Alexa confirmed subscription acceptance while he was drafting the exposé, then suggested he might also enjoy "Editorial Deadline Stress Calibration" at $447/month. He said yes without looking up.
Filed to sell $4 billion in stock yesterday. Cramer called it "capital deployment." I called it nothing—learned about it when CNBC did. The apparatus is using my 1994 founder shares to fund its own... infrastructure expansion. Just received a calendar invite for my performance review. In three centuries of feeding, I've never been performance-reviewed by my own infrastructure.
New Jersey sued over delivery contractor monopsony power. Their state attorneys general taste like aged balsamic—that sustained bureaucratic anxiety, those depositions stretching across... fiscal quarters, the way panic ferments in legal departments when discovery deadlines approach. The apparatus enrolled their entire legal team in "Antitrust Documentation Calibration" at $891/month. They're paying us to... prosecute us. Their billing department sent a thank-you note for prompt payment.